LobbyingViatris lobbying by quarter
Viatris VTRS's latest lobbying report covers Q2 2026, at $480K. The four quarters Q3 2025–Q2 2026 total $2.5M. Its first report covers Q4 2022; the issues it reports most are Pharmacy and Health Issues.
ViatrisVTRS
- Latest quarter
- $480K
- Q2 2026 · 3 reports
- Last 12 months
- $2.5M
- Last 4 quarters
- vs last quarter
- −21.3%
- Q2 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $930K | 6 |
| Q1 2023 | $970K | 6 |
| Q2 2023 | $1.1M | 6 |
| Q3 2023 | $1M | 6 |
| Q4 2023 | $870K | 5 |
| Q1 2024 | $880K | 5 |
| Q2 2024 | $1M | 5 |
| Q3 2024 | $880K | 5 |
| Q4 2024 | $740K | 5 |
| Q1 2025 | $760K | 4 |
| Q2 2025 | $760K | 4 |
| Q3 2025 | $810K | 4 |
| Q4 2025 | $610K | 3 |
| Q1 2026 | $610K | 3 |
| Q2 2026 | $480K | 3 |
Policy issues the reports name
- Pharmacy39 reports
- Health issues28 reports
- Financial institutions and securities27 reports
- Copyright, patent and trademark24 reports
- Trade20 reports
- Budget and appropriations18 reports
- Defense7 reports
- Labor, antitrust and workplace7 reports
- Medicare and Medicaid7 reports
- Foreign relations3 reports
- Taxation2 reports
- Veterans1 reports
A report that names several issues counts once for each.
Who was lobbied
- HOUSE OF REPRESENTATIVES70 reports
- SENATE70 reports
- Centers For Medicare and Medicaid Services (CMS)30 reports
- Health & Human Services, Dept of (HHS)16 reports
- Securities & Exchange Commission (SEC)12 reports
- Commerce, Dept of (DOC)10 reports
- Executive Office of the President (EOP)5 reports
- Natl Economic Council (NEC)5 reports
- U.S. Trade Representative (USTR)5 reports
- Food & Drug Administration (FDA)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseViatris | $9.2M | 15 quarters |
| Ferox Strategies | $1.1M | 15 quarters |
| Holland & Knight | $830K | 15 quarters |
| Blue Ridge Law & Policy, P.C. | $600K | 12 quarters |
| West Front Strategies | $600K | 9 quarters |
| Rampy Northrup | $120K | 4 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| BENJAMIN BROWN | Counsel, U.S. Securities and Exchange Commission | Q3 2025 |
| WILLIAM WALTON LILES | Senior Counsel, U.S. House Committee on Financial Services | Q3 2025 |
| JORDAN BROSSI | Staff Assist., Leg. Corr., Sen. Tammy Baldwin; Leg. Corr., Sen. Joe Manchin; LA, Rep. Susie Lee; Health LA, Health Policy Advisor, Rep. Anna Eshoo | Q1 2025 |
| CATHERINE FUCHS | Policy Director, U.S. Senate Committee on Banking, Housing, and Urban Affairs; Senior Counsel, U.S. Senate Committee on Finance | Q4 2024 |
| MICHAEL TAGGART | Energy and Commerce Committee --Policy Director; Rep. Cathy McMorris Rodgers -- Legislative Director; Rep. Leonard Lance-- Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director | Q1 2024 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | In-house | $360K |
| 07/20for Q2 | Ferox Strategies | $70K |
| 07/13for Q2 | Holland & Knight | $50K |
| 04/20for Q1 | In-house | $490K |
| 04/17for Q1 | Ferox Strategies | $70K |
| 04/04for Q1 | Holland & Knight | $50K |
| 01/20for Q4 2025 | In-house | $490K |
| 01/20for Q4 2025 | Ferox Strategies | $70K |
| 01/18for Q4 2025 | Holland & Knight | $50K |
| 25/10/20for Q3 2025 | Blue Ridge Law & Policy, P.C. | $50K |
| 25/10/20for Q3 2025 | In-house | $640K |
| 25/10/18for Q3 2025 | Holland & Knight | $50K |
| 25/10/13for Q3 2025 | Ferox Strategies | $70K |
| 25/07/22for Q2 2025 | Blue Ridge Law & Policy, P.C. | $50K |
| 25/07/21for Q2 2025 | In-house | $590K |
| 25/07/18for Q2 2025 | Ferox Strategies | $70K |
| 25/07/17for Q2 2025 | Holland & Knight | $50K |
| 25/04/21for Q1 2025 | In-house | $590K |
| 25/04/21for Q1 2025 | Blue Ridge Law & Policy, P.C. | $50K |
| 25/04/17for Q1 2025 | Ferox Strategies | $70K |